ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-25787

Affected devices do not properly validate and sanitize Technology Object (TO) name rendered on the "Motion Control Diagnostics" page of the web interface.

Published May 12, 2026 · catalog updated Jul 14, 2026 · Affected devices do not

Check if you run it

No confirmed exploitation is on record for CVE-2026-25787. EPSS is 0.54%. Act only if a listed version of Affected devices do not is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (Affected devices do not).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Critical9.3
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.54%
Remediation
Not established
Affected products
See sources for product scope

Affected devices do not properly validate and sanitize Technology Object (TO) name rendered on the "Motion Control Diagnostics" page of the web interface. This could allow an authenticated attacker who is authorized to download a TIA project into the product, to inject malicious scripts into the page. If a benign user with appropriate rights accesses the "Motion Control Diagnostics" parameters page, the malicious code would be executed in the scope of their web session.

No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.

How to fix CVE-2026-25787

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-25787. EPSS is 0.54%. Act only if a listed version of Affected devices do not is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-79: Cross-site Scripting (XSS). EPSS 0.54%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. May 12, 2026 · NIST NVD

    Detected

    Affected devices do not properly validate and sanitize Technology Object (TO) name rendered on the "Motion Control Diagnostics" page of the web interface. This could allow an authenticated attacker who is authorized to download a TIA project into the product, to inject malicious scripts into the page. If a benign user with appropriate rights accesses the "Motion Control Diagnostics" parameters pag

  2. Jul 14, 2026 · NIST NVD

    Updated

    Affected devices do not properly validate and sanitize Technology Object (TO) name rendered on the "Motion Control Diagnostics" page of the web interface. This could allow an authenticated attacker who is authorized to download a TIA project into the product, to inject malicious scripts into the page. If a benign user with appropriate rights accesses the "Motion Control Diagnostics" parameters pag

Sources

  • CVE.orgVulnerability recordCVE-2026-25787

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-25787

    30-day exploitation probability 0.5%

    first.org
  • NIST NVDVulnerability recordCVE-2026-25787

    Affected devices do not properly validate and sanitize Technology Object (TO) name rendered on the "Motion Control Diagnostics" page of the web interface. This could allow an authenticated attacker who is authorized to download a TIA project into the product, to inject malicious

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.